Pacific BioSciences of California Overview
- Year Founded
-
2004
- Status
-
Public
- Employees
-
485
- Stock Symbol
-
PACB
- Investments
-
4
- Share Price
-
$1.96
- (As of Friday Closing)
Pacific BioSciences of California General Information
Description
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.
Contact Information
Website
www.pacb.comCorporate Office
- 1305 O'Brien Drive
- Menlo Park, CA 94025
- United States
Corporate Office
- 1305 O'Brien Drive
- Menlo Park, CA 94025
- United States
Pacific BioSciences of California Stock Performance
As of 13-Nov-2026, Pacific BioSciences of California’s stock price is $1.96. Its current market cap is $610M with 312M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.96 | $1.97 | $1.07 - $3.44 | $610M | 312M | 12.4M | -$0.42 |
Pacific BioSciences of California Financials Summary
As of 30-Sep-2026, Pacific BioSciences of California has a trailing 12-month revenue of $161M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 1,205,923 | 965,993 | 988,202 | 2,791,392 |
| Revenue | 161,394 | 160,005 | 154,014 | 200,521 |
| EBITDA | (104,869) | (152,692) | (242,772) | (277,282) |
| Net Income | (131,233) | (546,376) | (309,851) | (306,735) |
| Total Assets | 721,096 | 784,083 | 1,260,447 | 1,746,013 |
| Total Debt | 705,369 | 702,422 | 672,434 | 933,930 |
Pacific BioSciences of California Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Pacific BioSciences of California Comparisons
Industry
Financing
Details
Pacific BioSciences of California Competitors (16)
One of Pacific BioSciences of California’s 16 competitors is 10x Genomics, a Formerly VC-backed company based in Pleasanton, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| 10x Genomics | Formerly VC-backed | Pleasanton, CA | ||||
| Bionano Genomics | Formerly VC-backed | San Diego, CA | ||||
| Oxford Nanopore Technologies | Formerly VC-backed | Oxford, United Kingdom | ||||
| Miltenyi Biotec | Private Debt Financed | Bergisch Gladbach, Germany | ||||
| Mammoth Biosciences | Venture Capital-Backed | Brisbane, CA |
Pacific BioSciences of California Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Pacific BioSciences of California Patents
Pacific BioSciences of California Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260357340-A1 | Integrated illumination of optical analytical devices | Pending | 29-Dec-2025 | ||
| US-20260201468-A1 | Arrays of integrated analytical devices with improved collection efficiency and use of the arrays in optical analysis | Pending | 09-Dec-2024 | ||
| WO-2026128420-A1 | Arrays of integrated analytical devices with improved collection efficiency and use of the arrays in optical analysis | Pending | 09-Dec-2024 | ||
| US-20260015601-A1 | Improved loading of molecules and complexes to reaction sites | Pending | 15-Jul-2024 | ||
| WO-2026019720-A1 | Improved loading of molecules and complexes to reaction sites | Pending | 15-Jul-2024 | C12N9/1241 |
Pacific BioSciences of California Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Pacific BioSciences of California Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Pacific BioSciences of California Investments & Acquisitions (4)
Pacific BioSciences of California’s most recent deal was a Seed Round with Blank Bio for . The deal was made on 19-May-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Blank Bio | 19-May-2026 | Seed Round | Discovery Tools (Healthcare) | ||
| Apton Biosystems | 02-Aug-2023 | Merger/Acquisition | Diagnostic Equipment | ||
| Omniome | 20-Sep-2021 | Merger/Acquisition | Biotechnology | ||
| Circulomics | 20-Jul-2021 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology |
Pacific BioSciences of California ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
22.39 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,585
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Laboratory Equipment and Services
Subindustry
of 67
Rank
Percentile
Pacific BioSciences of California FAQs
-
When was Pacific BioSciences of California founded?
Pacific BioSciences of California was founded in 2004.
-
Where is Pacific BioSciences of California headquartered?
Pacific BioSciences of California is headquartered in Menlo Park, CA.
-
What is the size of Pacific BioSciences of California?
Pacific BioSciences of California has 485 total employees.
-
What industry is Pacific BioSciences of California in?
Pacific BioSciences of California’s primary industry is Other Healthcare Technology Systems.
-
Is Pacific BioSciences of California a private or public company?
Pacific BioSciences of California is a Public company.
-
What is Pacific BioSciences of California’s stock symbol?
The ticker symbol for Pacific BioSciences of California is PACB.
-
What is the current stock price of Pacific BioSciences of California?
As of 13-Nov-2026 the stock price of Pacific BioSciences of California is $1.96.
-
What is the current market cap of Pacific BioSciences of California?
The current market capitalization of Pacific BioSciences of California is $610M.
-
What is Pacific BioSciences of California’s current revenue?
The trailing twelve month revenue for Pacific BioSciences of California is $161M.
-
Who are Pacific BioSciences of California’s competitors?
10x Genomics, Bionano Genomics, Oxford Nanopore Technologies, Miltenyi Biotec, and Mammoth Biosciences are some of the 16 competitors of Pacific BioSciences of California.
-
What is Pacific BioSciences of California’s annual earnings per share (EPS)?
Pacific BioSciences of California’s EPS for 12 months was -$0.42.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
